These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8060249)

  • 1. The adequacy of fragmin as a single bolus dose with reused dialyzers.
    Kerr PG; Mattingly S; Lo A; Atkins RC
    Artif Organs; 1994 Jun; 18(6):416-9. PubMed ID: 8060249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation.
    Am J Kidney Dis; 1997 Dec; 30(6):859-71. PubMed ID: 9398135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
    Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
    Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved dialyzer reuse after use of a population pharmacodynamic model to determine heparin doses.
    Ouseph R; Brier ME; Ward RA
    Am J Kidney Dis; 2000 Jan; 35(1):89-94. PubMed ID: 10620549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialyzer reprocessing with peroxyacetic acid as sole cleansing and sterilizing agent.
    Kes P; Reiner Z; Ratković-Gusić I
    Acta Med Croatica; 1997; 51(2):87-93. PubMed ID: 9204593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dialyzer reuse on survival of patients treated with hemodialysis.
    Feldman HI; Kinosian M; Bilker WB; Simmons C; Holmes JH; Pauly MV; Escarce JJ
    JAMA; 1996 Aug; 276(8):620-5. PubMed ID: 8773634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of fragmin in program hemodialysis of patients with terminal chronic renal failure].
    Kozlova TV; Shilo VIu; Denisov AIu
    Klin Med (Mosk); 2005; 83(9):45-9. PubMed ID: 16279040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.
    Islam MS; Hassan ZA; Chalmin F; Vido S; Berrada M; Verhelst D; Donnadieu P; Moranne O; Esnault VL
    Am J Kidney Dis; 2016 Nov; 68(5):752-762. PubMed ID: 27344212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of erythropoietin on dialyzer reuse, heparin need, and urea kinetics in maintenance hemodialysis patients.
    Veys N; Vanholder R; De Cuyper K; Ringoir S
    Am J Kidney Dis; 1994 Jan; 23(1):52-9. PubMed ID: 8285198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of heparin and dalteparin on oxidative stress during hemodialysis in patients with end-stage renal disease.
    Nassiri AA; Hakemi MS; Soulati M; Marashian M; Rahbar K; Azizi F
    Iran J Kidney Dis; 2009 Jul; 3(3):162-7. PubMed ID: 19617666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialyzer fiber bundle volume during hemodialysis using large-surface dialyzers.
    Leblanc M; Lafrance JP; Renald A
    ASAIO J; 2006; 52(6):646-51. PubMed ID: 17117054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single dose of a low molecular weight heparin fragment for anticoagulation during hemodialysis.
    Ljungberg B; Blombäck M; Johnsson H; Lins LE
    Clin Nephrol; 1987 Jan; 27(1):31-5. PubMed ID: 3815906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of erythropoietin treatment on dialyzer reuse.
    Kes P; Reiner Z; Starcević B; Ratković-Gusić I
    Blood Purif; 1997; 15(2):77-83. PubMed ID: 9087814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of low-dose low molecular weight heparin in hemodialysis.
    Lai KN; Wang AY; Ho K; Szeto CC; Li M; Wong LK; Yu AW
    Am J Kidney Dis; 1996 Nov; 28(5):721-6. PubMed ID: 9158210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of bleach cleaning on the performance of dialyzers with polysulfone membranes processed for reuse using peracetic Acid.
    Ward RA; Ouseph R
    Artif Organs; 2003 Nov; 27(11):1029-34. PubMed ID: 14616521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center.
    Lord H; Jean N; Dumont M; Kassis J; Leblanc M
    Am J Nephrol; 2002; 22(1):58-66. PubMed ID: 11919404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hemodialyzer reuse: dissociation between clearances of small and large solutes.
    Leypoldt JK; Cheung AK; Deeter RB
    Am J Kidney Dis; 1998 Aug; 32(2):295-301. PubMed ID: 9708616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of heparin-grafted hemodialysis membranes: impact on monocyte chemoattractant protein-1 circulating level and oxidative status.
    Morena M; Jaussent I; Chalabi L; Bargnoux AS; Dupuy AM; Badiou S; Rakic C; Thomas M; Canaud B; Cristol JP; Michel F
    Hemodial Int; 2010 Oct; 14(4):403-10. PubMed ID: 20955273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation with micro-CT of different anticoagulation strategies during hemodialysis in patients with thrombocytopenia: A randomized crossover study.
    Vanommeslaeghe F; De Somer F; Josipovic I; Boone M; Dhondt A; Van Biesen W; Eloot S
    Artif Organs; 2019 Aug; 43(8):756-763. PubMed ID: 30820962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.